Fernando O. Recio

1.3k total citations
45 papers, 994 citations indexed

About

Fernando O. Recio is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Fernando O. Recio has authored 45 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Reproductive Medicine, 17 papers in Surgery and 15 papers in Obstetrics and Gynecology. Recurrent topics in Fernando O. Recio's work include Ovarian cancer diagnosis and treatment (18 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Fernando O. Recio is often cited by papers focused on Ovarian cancer diagnosis and treatment (18 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Fernando O. Recio collaborates with scholars based in United States, Australia and United Kingdom. Fernando O. Recio's co-authors include Ronald E. Hempling, M. Steven Piver, Gamal H. Eltabbakh, David Gal, Deborah L. Driscoll, Leslie E. Blumenson, M.Steven Piver, M.L. Tancer, Jeffrey M. Goldberg and Trudy R. Baker and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer.

In The Last Decade

Fernando O. Recio

44 papers receiving 964 citations

Peers

Fernando O. Recio
W. Schröder Germany
C. Sessa Switzerland
Taymaa May Canada
Maureen A. Riopel United States
Emanuela Veras United States
Larry E. Puls United States
R E Scully United States
W. Schröder Germany
Fernando O. Recio
Citations per year, relative to Fernando O. Recio Fernando O. Recio (= 1×) peers W. Schröder

Countries citing papers authored by Fernando O. Recio

Since Specialization
Citations

This map shows the geographic impact of Fernando O. Recio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando O. Recio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando O. Recio more than expected).

Fields of papers citing papers by Fernando O. Recio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando O. Recio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando O. Recio. The network helps show where Fernando O. Recio may publish in the future.

Co-authorship network of co-authors of Fernando O. Recio

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando O. Recio. A scholar is included among the top collaborators of Fernando O. Recio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando O. Recio. Fernando O. Recio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Sarfraz, Fernando O. Recio, Ahmad Awada, et al.. (2024). Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer. International Journal of Gynecological Cancer. 34(7). 977–984. 2 indexed citations
2.
Recio, Fernando O., Carly Bess Scalise, Melissa Lumish, et al.. (2024). Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies. Gynecologic Oncology. 182. 63–69. 11 indexed citations
3.
Recio, Fernando O., Brian Orr, Young Kwang Chae, et al.. (2023). Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies (2297). Gynecologic Oncology. 176. S313–S314. 1 indexed citations
4.
Recio, Fernando O., Ahmad Awada, Theresa Kuhn, et al.. (2023). Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer. Gynecologic Oncology. 175. 93–96. 1 indexed citations
5.
Recio, Fernando O., et al.. (2022). Fused Clitoral Hood Presenting as a Periclitoral Mass. Obstetrics and Gynecology. 140(6). 1056–1060.
6.
Hale, Andrew T., Fernando O. Recio, Mohammad A. Shatat, et al.. (2014). Endothelial Krüppel-like Factor 4 Regulates Angiogenesis and the Notch Signaling Pathway. Journal of Biological Chemistry. 289(17). 12016–12028. 65 indexed citations
7.
Dalton, Heather J., James V. Fiorica, Candace K. McClure, et al.. (2014). In vitro chemoresponse in metachronous pairs of gyneclologic cancers. PubMed. 1(1). 7–7. 1 indexed citations
8.
Eltabbakh, Gamal H., et al.. (1999). Laparoscopic management of women with a family history of ovarian cancer. Journal of Surgical Oncology. 72(1). 9–13. 15 indexed citations
9.
Silver, David F., Ronald E. Hempling, Fernando O. Recio, M. Steven Piver, & Gamal H. Eltabbakh. (1998). Complications Related to Indwelling Caval Catheters on a Gynecologic Oncology Service. Gynecologic Oncology. 70(3). 329–333. 13 indexed citations
10.
Piver, M.Steven, et al.. (1998). Prolonged Disease-Free Survival by Maintenance Chemotherapy among Patients with Recurrent Platinum-Sensitive Ovarian Cancer. Gynecologic Oncology. 71(2). 190–195. 18 indexed citations
11.
Recio, Fernando O., M. Steven Piver, Ronald E. Hempling, Gamal H. Eltabbakh, & Seung S. Hahn. (1998). Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: Results of a pilot study. International Journal of Radiation Oncology*Biology*Physics. 40(2). 411–414. 20 indexed citations
12.
Eltabbakh, Gamal H., M.Steven Piver, Ronald E. Hempling, et al.. (1998). Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer. Gynecologic Oncology. 70(3). 392–397. 32 indexed citations
13.
Eltabbakh, Gamal H., et al.. (1997). Estrogen Replacement Therapy Following Oophorectomy in Women with a Family History of Ovarian Cancer. Gynecologic Oncology. 66(1). 103–107. 10 indexed citations
14.
Piver, M. Steven, Gamal H. Eltabbakh, Ronald E. Hempling, Fernando O. Recio, & Leslie E. Blumenson. (1997). Two Sequential Studies for Primary Peritoneal Carcinoma: Induction with Weekly Cisplatin Followed by either Cisplatin–Doxorubicin–Cyclophosphamide or Paclitaxel–Cisplatin. Gynecologic Oncology. 67(2). 141–146. 29 indexed citations
15.
Hempling, Ronald E., et al.. (1997). The Addition of Bleomycin and Dose-Escalated Ifosfamide to the Combination of Cisplatin Plus Ifosfamide Does Not Improve Survival in Advanced or Recurrent Cervical Carcinoma. American Journal of Clinical Oncology. 20(3). 315–318. 6 indexed citations
16.
Recio, Fernando O., M. Steven Piver, Ronald E. Hempling, & Deborah L. Driscoll. (1996). Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer. 78(10). 2157–2163. 82 indexed citations
17.
Recio, Fernando O., M. Steven Piver, & Ronald E. Hempling. (1996). Pretreatment Transperitoneal Laparoscopic Staging Pelvic and Paraaortic Lymphadenectomy in Large (≥5 cm) Stage IB2 Cervical Carcinoma: Report of a Pilot Study. Gynecologic Oncology. 63(3). 333–336. 28 indexed citations
18.
Piver, M. Steven, Fernando O. Recio, Trudy R. Baker, & Deborah Driscoll. (1994). Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer. Cancer. 73(6). 1693–1698. 22 indexed citations
19.
Piver, M.Steven, et al.. (1993). A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Cancer. 71(7). 2245–2249. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026